US Stocks
/
Korro Bio, Inc. Share Price

Korro Bio, Inc. Share Price

NASDAQ: KRRO | Micro Cap
$12.18
+$0.63 (5.45%) Last updated on 07 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Korro Bio, Inc. Stock Performance

Open
$11.44
Prev. Close
$11.55
Circuit Range
N/A
Day Range
$11.40 - $12.18
Year Range
$5.21 - $54.75
Volume
4,167
Average Traded
$11.75

Korro Bio, Inc. Share Price Today

As of 9 August 2026, Korro Bio, Inc.'s share price is $12.18. The stock opened at $11.44, compared to its previous close of $11.55. During today's trading session, Korro Bio, Inc.'s share price traded between $11.40 and $12.18, with an average price of $11.79. Over the past 52 weeks, the stock has recorded a high of $54.75 and a low of $5.21. In terms of performance, Korro Bio, Inc.'s share price has risen by 2.27% over the last six months and is down 47.18% on a year-on-year basis.

Korro Bio, Inc. Share Price Chart

$11.40$12.18
L
Show Current Price
H

Korro Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$114.44M
PE Ratio (TTM)
-0.98
Dividend Yield
N/A
EPS (TTM)
$-12.48
Revenue (TTM)
$6.39M
Return On Equity (TTM)
-227.96%
Profit Margin
-1834.48%
Debt to Equity
0.23
Quarterly Earnings Growth YoY
N/A

Korro Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2025Jun 2025Sep 2025
Revenue$2.55M$1.46M$1.09M
Net Profit-$23.39M-$25.77M-$18.06M
Net Profit Margin-917.14%-1765.07%-1656.97%
Income ChangeN/A-10.19%29.91%

Korro Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$2.27M$6.39M
Net Profit-$83.58M-$117.26M
Net Profit Margin-3680.36%-1834.48%
Income ChangeN/A-40.30%

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Korro Bio, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$10.69
$11.54
+11.71%
Jul 2026
$13.11
$10.33
-21.27%
Jun 2026
$13.10
$13.12
-2.27%
May 2026
$13.27
$13.43
+1.02%
Apr 2026
$11.76
$13.29
+17.20%
Mar 2026
$11.55
$11.34
-4.79%
Feb 2026
$13.26
$11.91
-10.59%
Jan 2026
$7.99
$13.32
+66.08%
Dec 2025
$5.54
$8.02
+40.70%
Nov 2025
$39.88
$5.70
-86.09%
Oct 2025
$48.17
$40.97
-14.16%
Sep 2025
$22.63
$47.73
+106.98%

KRRO Share Price FAQs

What is Korro Bio, Inc. share price today?

chevron-up
Korro Bio, Inc. share price today is $12.18 as on August 7, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Korro Bio, Inc. stock?

chevron-up
The 52 week high of Korro Bio, Inc. stock is $54.75, while the 52 week low is $5.21 as of 7 Aug '26.

What is KRRO's market capitalisation today?

chevron-up
KRRO market capitalisation is $114.44M as of August 9, 2026, at 11:11 am IST.

What is KRRO's net income for the last quarter?

chevron-up
KRRO's net income for the last quarter is -0.02B USD.

What is the 5 year returns of KRRO?

chevron-up
The 5 year returns of KRRO is -96.84% as on 7 Aug '26.

What is the high & low stock price of KRRO today?

chevron-up
KRRO stock price hit a high of $12.18 and low of $11.40 as of 7 Aug '26.

Can I buy KRRO shares in India?

chevron-up
Yes. You can buy KRRO in India by opening an international trading account.